Cardiovascular and Liver Function Alterations in Patients with Parkinson’s Disease

Inogamova Nigora Abdulkhayevna

doi:10.51699/cajmns.v7i2.3152

Authors

Inogamova Nigora Abdulkhayevna PhD, Lecturer, Department of Internal Medicine, Alfraganus University, Tashkent, Uzbekistan

DOI:

https://doi.org/10.51699/cajmns.v7i2.3152

Keywords:

Parkinson’s Disease, Cardiovascular Dysfunction, Liver Function, Autonomic Dysregulation, Non-Motor Symptoms, Orthostatic Hypotension

Abstract

Parkinson's disease (PD) is a complex neurodegenerative disorder that is mainly known for its movement deficits; however, its systemic effects spread to the cardiovascular and hepatic functions. This review summarises the current evidence for autonomic cardiovascular changes and liver function changes in PD patients. Findings suggest that there is a high prevalence of orthostatic hypotension, decreased heart rate variability and impaired baroreflex sensitivity, indicating significant autonomic dysfunction. Concurrently, very mild elevation of liver enzymes and a more pronounced elevation of fibrosis scores indicate a subclinical hepatic involvement, which may be related to disease severity. Recognising these systemic manifestations is important for the full patient management, early recognition of complications and quality of life improvement. The inclusion of evaluation of cardiovascular and liver function in routine care might help to design specific interventions and contribute to a holistic approach in the management of PD beyond the motor symptoms.

References

Pilipovich AA, Vorob’eva OV, Makarov SA. Correlation of motor symptoms and cardiovascular dysfunction in Parkinson’s disease. Zh Nevrol Psikhiatr Im S S Korsakova. 2025;125(4):59–67. doi:10.17116/jnevro202512504159.

Pérez T, Tijero B, Gabilondo I, Luna A, Llorens VL, Berganzo K, et al. Cardiocirculatory manifestations in Parkinson’s disease patients without orthostatic hypotension. J Hum Hypertens. 2015;29(10):604–9. doi:10.1038/jhh.2014.131.

Pitton Rissardo J, Gadelmawla AF, Khalil I, Abdulgadir A, Bhatti KS, Caprara ALF. Epidemiology of autonomic dysfunction in Parkinson’s disease: a review. Med Int (Lond). 2025;5(6):68. doi:10.3892/mi.2025.267.

Cernanova Krohova O, et al. Early parasympathetic dysfunction in Parkinson’s disease: insights from information theoretic analysis. PubMed. 2025.

Kim JS, Lee SH, Oh YS, Park JW, An JY, Park SK, et al. Cardiovascular autonomic dysfunction in mild and advanced Parkinson's disease. J Mov Disord. 2016;9(2):97–103. doi:10.14802/jmd.16001.

Arnao V, Cinturino AC, Mastrilli S, Buttà C, Maida C, Tuttolomondo A, et al. Impaired circadian heart rate variability in Parkinson's disease: a time domain analysis in ambulatory setting. BMC Neurol. 2020;20(1):152. doi:10.1186/s12883 020 01722 3.

Meksi K, Garasto E, Bovenzi R, Mercuri NB, Stefani A, Rocchi C. Gender specific cardiovascular autonomic responses in Parkinson’s disease: insights from an observational study. Parkinsonism Relat Disord. 2025;137:107902. doi:10.1016/j.parkreldis.2025.107902.

Li Y, Wang J, Li X, Jing W, Omorodion I, Liu L. Association between heart rate variability and Parkinson’s disease: a meta analysis. Curr Pharm Des. 2021;27(17):2056–67. doi:10.2174/1871527319666200905122222.

Mehta S. Cardiovascular autonomic dysfunction in idiopathic Parkinson’s disease. Ann Indian Acad Neurol. 2022;25(5):803–4. doi:10.4103/aian.aian_704_22.

Sigawi T, Hamtzany O, Hurvitz N, Ishay Y, Dayan R, Arkadir D, Ilan Y. Investigating the relationship between chronic liver cirrhosis and Parkinsonism: a comparative analysis and a suggested diagnostic scheme. Clin Pract. 2024;14(4):1375–82. doi:10.3390/clinpract14040110.

Ilan Y, Capasso A. Investigating the relationship between chronic liver cirrhosis and Parkinson’s disease. PMCID. 2024;PMC11270255.

Tanner CM. Liver enzyme abnormalities in Parkinson’s disease. Geriatrics. 1991;46 Suppl 1:60–3. PubMed PMID: 1894148.

Khalil I, Sayad R, Kedwany AM, Hamdy Sayed H, Caprara ALF, Rissardo JP. Cardiovascular dysautonomia and cognitive impairment in Parkinson’s disease. Med Int (Lond). 2024;4(6):70. doi:10.3892/mi.2024.194.

Zhang H, Tao Y, Wen Z, Wang H, Liang Q, Liu Q, et al. Factors associated with orthostatic hypotension in Parkinson’s disease: a systematic review and meta analysis. J Vis Exp. 2025; (69191).

Epidemiology of autonomic dysfunction prevalence in Parkinson’s disease nonmotor symptoms. Preprints.org. 2025.

Parkinson’s disease metabolic and systemic implications: metabolic dysfunction and PD link. Front Aging Neurosci. 2025.

Chen Y, Ma M, Zhang R, et al. Dairy rich diet triggers hepatic α synuclein pathology via the liver brain axis in GBA1 related Parkinson’s disease. npj Parkinsons Dis. 2025;11(361). doi:10.1038/s41531 025 01211 9.